These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Some further comments on aseptic processing guidance, or the fool on the hill: Parenteral Drug Association. Agalloco J PDA J Pharm Sci Technol; 2003; 57(5):324-30. PubMed ID: 14677624 [No Abstract] [Full Text] [Related]
4. PDA's response to FDA's "Guideline on sterile drug products produced by aseptic processing". Akers JE; Agalloco JP; Carleton FJ; Korczynski MS J Parenter Sci Technol; 1988; 42(4):114-7. PubMed ID: 3183865 [No Abstract] [Full Text] [Related]
5. Justification for the use of aseptic filling for sterile injectable products. Cundell AM PDA J Pharm Sci Technol; 2014; 68(4):323-32. PubMed ID: 25035255 [TBL] [Abstract][Full Text] [Related]
6. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations. Hasanain F; Guenther K; Mullett WM; Craven E PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600 [TBL] [Abstract][Full Text] [Related]
12. Considerations for the Terminal Sterilization of Oligonucleotide Drug Products. DeCollibus DP; Searcy J; Tivesten A; Akhtar N; Lindenberg C; Abarrou N; Pradhan S; Fiandaca M; Franklin J; Govindan G; Liu HY; Royle D; Soo PL; Storch K Nucleic Acid Ther; 2023 Jun; 33(3):159-177. PubMed ID: 36787481 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Bacillus oleronius as a Biological Indicator for Terminal Sterilization of Large-Volume Parenterals. Izumi M; Fujifuru M; Okada A; Takai K; Takahashi K; Udagawa T; Miyake M; Naruyama S; Tokuda H; Nishioka G; Yoden H; Aoki M PDA J Pharm Sci Technol; 2016; 70(1):30-8. PubMed ID: 26889054 [TBL] [Abstract][Full Text] [Related]
14. Aseptic processing contamination case studies and the pharmaceutical quality system. Friedman RL PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544 [TBL] [Abstract][Full Text] [Related]
15. PDA response. FDA proposal to amend cGMP's entitled--use of aseptic processing and terminal sterilization in the preparation of sterile pharmaceuticals for human and veterinary use. Parenteral Drug Association. J Parenter Sci Technol; 1992; 46(3):65-8. PubMed ID: 1522442 [No Abstract] [Full Text] [Related]
18. Top ten hot topics in parenteral science and technology. Akers MJ; Nail SL; Saffell-Clemmer W PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174 [TBL] [Abstract][Full Text] [Related]
19. [Hygienic precautions and microbiological quality control during the manufacturing of sterile drugs]. Züge R Zentralbl Bakteriol Mikrobiol Hyg B; 1982 May; 176(2-3):134-41. PubMed ID: 7124163 [TBL] [Abstract][Full Text] [Related]